Emergent cleared to begin Covid-19 vaccine manufacturing at Baltimore plant
Published
The vaccine maker would resume operations for the first time in more than three months.
Full ArticlePublished
The vaccine maker would resume operations for the first time in more than three months.
Full ArticleThe vaccine maker would resume operations for the first time in more than three months.